Anatomical Specialization of Myristica fragrans Houtt. Extracts: Targeted Antimicrobial Efficacy Against Veterinary Cutaneous Pathogens
Main Article Content
บทคัดย่อ
The escalating global crisis of antimicrobial resistance (AMR) in veterinary practice necessitates the urgent development of sustainable, plant-derived topical agents for managing cutaneous infections. This study systematically evaluated the antimicrobial potency of 75% ethanol extracts from three distinct anatomical fractions of nutmeg (Myristica fragrans Houtt.); the pericarp, seed coat (mace), and kernel; against major veterinary pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, S. epidermidis, and Streptococcus pyogenes. Using the agar well diffusion method, the extracts demonstrated significant anatomical specialization in their inhibitory profiles. The pericarp extract exhibited the broadest antimicrobial spectrum at 500 mg/mL, with inhibition zones reaching up to 29.40 ± 1.31 mm; however, its activity was attenuated at lower concentrations (≤125 mg/mL). In contrast, the kernel extract demonstrated remarkable inhibition efficacy, maintaining potent inhibitory zones (14.70–17.30 mm) against S. aureus, S. epidermidis, and S. pyogenes even at the lowest concentration of 125 mg/mL, suggesting the presence of highly active, dilution-stable compounds. Thin-layer chromatography profiling revealed that each fraction possesses distinct phytochemical fingerprints, correlating with their varying biological activities. These findings substantiate the necessity of targeted extraction strategies over whole-fruit processing to optimize therapeutic yield. Consequently, nutmeg-derived kernel and pericarp fractions represent promising natural candidates for integration into veterinary dermatological formulations to mitigate infection and address the AMR challenge.
Article Details

อนุญาตภายใต้เงื่อนไข Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของ PBRU Science Journal
เอกสารอ้างอิง
Dina MA, Bhutta MA, Zeshan SA. Global burden and future outlook of antimicrobial resistance. Int J Clin Microbiol Biochem Technol 2026;9:18-21.
Ramadhan F, Nugroho YE, Faizal IA. Inhibitory effect of nutmeg (Myristica fragrans) leaf extract on biofilm formation by methicillin-resistant Staphylococcus aureus (MRSA). JoIMedLabS 2025;6:122-31.
Jasim AA, Al-Saedi F, Mahmoud BS. Antibacterial activity of nutmeg (Myristica fragrans) seeds extracts against pathogenic bacteria isolated from infected wounds. NanoMatImp 2025;1:17-23.
Shafiei Z, Shuhairi NN, Md Fazly Shah Yap N, Harry Sibungkil CA, Latip J. Antibacterial activity of Myristica fragrans against oral pathogens. eCAM 2012;2012:825362.
Kaur V, Kaushal S, Kalia A, Jangra R, Sharma P. Antimicrobial, synergistic and antibiofilm activities of Myristica fragrans Houtt. bioactive compounds and their derivatives. Sci Rep 2025;15:33041.
Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004;4:211-22.
Lee HJ, Kim M. Skin barrier function and the microbiome. Int J Mol Sci 2022;23:13071.
Linz MS, Mattappallil A, Finkel D, Parker D. Clinical impact of Staphylococcus aureus skin and soft tissue infections. Antibiotics (Basel) 2023;12.
Oh J, Voigt AY. The human skin microbiome: from metagenomes to therapeutics. Nat. Rev. Microbiol. 2025;23:771-87.
Severn MM, Horswill AR. Staphylococcus epidermidis and its dual lifestyle in skin health and infection. Nat Rev Microbiol 2022;21:97-111.
Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN. Pseudomonas skin infection: clinical features, epidemiology, and management. Am J Clin Dermatol 2011;12:157-69.
Porrello A, Sordillo A, Badalamenti N, et al. Myristicin from Athamanta sicula L.: a potential natural antimicrobial agent. Antibiotics 2026;15:79.
Silva ACR da, Lopes PM, Azevedo MMB de, Costa DCM, Alviano CS, Alviano DS. Biological activities of a-pinene and β-pinene enantiomers. Molecules 2012;17:6305-16.
Ha MT, Vu NK, Tran TH, Kim JA, Woo MH, Min BS. Phytochemical and pharmacological properties of Myristica fragrans Houtt.: an updated review. Arch Pharm Res 2020;43:1067-1092.
Farahpour MR, Pirkhezr E, Ashrafian A, Sonboli A. Accelerated healing by topical administration of Salvia officinalis essential oil on Pseudomonas aeruginosa and Staphylococcus aureus infected wound model. Biomed Pharmacother 2020;128:110120.
Serra R, Grande R, Butrico L, Rossi A, Settimio UF, Caroleo B, et al. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther 2015;13:605-13.
Hooda P, Kanhaiya K, Kumar M, Mudgil A. Pharmacognostical, physicochemical, phytochemical, antioxidant, and antimicrobial evaluation of nutmeg (Myristica fragrans) seed extracts. Int J Pharmacol Pharm Res 2025;7:29-33.
Tariq D, Sultan MT, Noman AM, Raza H, Akram S, Mohamed HM, et al. Nutmeg beyond spice: a review on its therapeutic potential, safety and industrial promise. Food Sci Nutr 2025;13:e71053.
Abourashed EA, El-Alfy AT. Chemical diversity and pharmacological significance of the secondary metabolites of nutmeg (Myristica fragrans Houtt.). Phytochem Rev 2016;15:1035-56.
Ashokkumar K, Simal-Gandara J, Murugan M, Dhanya MK, Pandian A. Nutmeg (Myristica fragrans Houtt.) essential oil: a review on its composition, biological, and pharmacological activities. Phytother Res 2022;36:2839.
Elfia HY, Susilo S. An update on the pharmacology, phytochemistry, and toxicity of Myristica fragrans Houtt. as a source of treatment: a scoping review. J Appl Pharm Sci 2023;13:92-106.
Putra NR, Aziz AHA, Mamat H, Rizkiyah DN, Yanus MAC, Irianto I, et al. Green extraction of nutmeg (Myristica fragrans) phytochemicals: prospective strategies and roadblocks. Open Agric 2024;9.
Rajan R, Cherian E. The nutmeg pericarp (Myristica fragrans) as a functional food ingredient: phytochemicals, bioactivities and valorization prospects. APPS 2026;2:25.
Nikolic V, Nikolic L, Dinic A, Gajic I, Urosevic M, Stanojevic L, et al. Chemical composition, antioxidant and antimicrobial activity of nutmeg (Myristica fragrans Houtt.) seed essential oil. J Essent Oil-Bear Plants 2021;24:218-27.
Lv Y, Hao J, Wang Y, Du K, Kang K, Xin Y, et al. Insight into the antibacterial properties of terpinen-4-ol on planktonic growth and biofilm-formation of Vibrio parahaemolyticus. Food Biosci 2024;59:104037.
Nair VG, Unnikrishnan VK, Muralidharan N, Venkatathri BNS, Lowrence RC, Rajesh YBRD, et al. Human vaginal Lactobacillus Jensenii -derived (-)-terpinen-4-ol restores antibiotic sensitivity by inhibiting efflux pumps in drug resistant E. coli and K. pneumoniae. Sci Rep 2025;15:31823.
Mondello F, Fontana S, Scaturro M, Girolamo A, Colone M, Stringaro A, et al. Terpinen-4-ol, the main bioactive component of tea tree oil, as an innovative antimicrobial agent against Legionella pneumophila. Pathogens 2022;11:682.
Emre Özkan O, Olgun Ç, Güney B, Gür M, Güney K, Ateş S. Chemical composition and antimicrobial activity of Myristica fragrans & Elettaria cardamomum essential oil. J For Fac 2018;18:225-9.
Ibrahim KM, Naem RK, Abd-Sahib AS. Antibacterial activity of nutmeg (Myristica fragrans) seed extracts against some pathogenic bacteria. JNUS 2013;16:188-192.
Oo T, Saiboonjan B, Srijampa S, Srijampa S, Srisrattakarn A, Sutthanut K, et al. Inhibition of bacterial efflux pumps by crude extracts and essential oil from Myristica fragrans Houtt. (Nutmeg) seeds against methicillin-resistant Staphylococcus aureus. Molecules 2021;26:4662.
Bannach TC, Mongruel ACB, Evangelista AG, Souza VBM, Voi R, Otuki MF, et al. Comparative efficacy of a novel topical formulation with antimicrobial peptides and encapsulated plant extracts versus conventional therapies for canine otitis externa. Pathogens 2025;14:1112.
Sheinberg Waisburd G, Romero Núñez C, Martin Cordero A, Heredia Cárdenas R, Flores Ortega A. Efficacy of plant extract-based solutions compared to chlorhexidine and miconazole shampoo for the treatment of superficial pyoderma in dogs. Vet Med Sci 2025;11:e70075.
Seneme EF, Dos Santos DC, Silva EMR, Franco YEM, Longato GB. Pharmacological and therapeutic potential of myristicin: a literature review. Molecules 2021;26:5914.